PRTCMICRO

PureTech Health plc

HealthcareBiotechnology
$17.54
$0.00(+0.69%)
52W$14.50
$19.92
Updated Jun 30, 02:00 AM
RSI50
RS Rating49/99
Beta0.56
Volatility46%
F-Score5/9
Mkt Cap$42M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

PureTech Health plc is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 49), showing significant lag compared to the market leaders. Earnings contraction of 9% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
49
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.56
vs S&P 500
DEFENSIVE
52W Position
56%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$17.15
50 SMA > 100 SMA$17.34
100 SMA > 150 SMA$17.18
150 SMA > 200 SMA$17.22

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$17.48+0.34%ABOVE
50 SMA$17.15+2.30%ABOVE
100 SMA$17.34+1.13%ABOVE
150 SMA$17.18+2.12%ABOVE
200 SMA$17.22+1.84%ABOVE

Price Performance

1D+0.7%
1W+0.0%
1M-5.2%
3M+21.0%
6M+3.2%
YTD+5.4%
1Y+1.7%
3Y-16.2%
52-Week Trading Range56% from low
$17.54
52W Low$14.50
52W High$19.92

Technical Indicators

RSI (14)NEUTRAL
50.4
305070
Setup ScoreWARM
7/10
Base depth: 27.5%

Risk Profile

Beta
0.56
52W Vol
46%
ATR
$0.41
Max DD (1Y)
-27%

Volume Analysis

Today
50D Avg
11.5K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'24-200%
$-1.50
Q4'24+975%
$3.50
Q2'25-322%
$-1.90
Q4'25-3487%
$-26.90
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-8.83%
5 Years:-10.99%
3 Years:+30.63%
TTM:-53.72%

Compounded Profit Growth

10 Years:-36.16%
5 Years:
3 Years:
TTM:-11.76%

Stock Price CAGR

10 Years:-7.56%
5 Years:-18.35%
3 Years:-16.19%
1 Year:+1.68%

Return on Equity

10Y Avg:1.7%
5Y Avg:-10.0%
3Y Avg:-10.5%
Last Year:-16.1%

Key Metrics

Market Cap$42M
Gross Margin1.0%
Net Margin-23.6%
Piotroski F-Score5/9

Frequently Asked Questions

Is PRTC in an uptrend right now?

PRTC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is PRTC overbought or oversold?

PRTC's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.

Is PRTC outperforming the market?

PRTC has a Relative Strength (RS) Rating of 49 out of 99. PRTC is currently lagging the broader market.

Where is PRTC in its 52-week range?

PRTC is trading at $17.54, which is 88% of its 52-week high ($19.92) and 56% above its 52-week low ($14.50).

How volatile is PRTC?

PRTC has a Beta of 0.56 and 52-week volatility of 46%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.